Eagles QB Jalen Hurts out for season after blood clots discovered in lungs, league sources say

Philadelphia Eagles quarterback Jalen Hurts is on blood thinners after additional testing revealed a deep vein thrombosis and blood clots in his lungs, his agent, Nicole Lynn, said in a joint statement with the team on Monday.

Hurts missed Sunday's game against the Carolina Panthers and was placed on injured reserve after what was initially described as a "superficial" blood clot in his left calf. 

League sources tell CBS News Philadelphia that Hurts is expected to miss the rest of the season.

Hurts' injury first came to light Oct. 8 when he requested treatment on his calf, saying he had been cleated during the Rams game on Oct. 4. A small blood clot was revealed by an ultrasound performed after the team's flight to London to face the Jacksonville Jaguars. Specialists in London at that time diagnosed Hurts with a superficial blood clot.

Hurts played in the London game, a heartbreaking, last-second loss to the Jaguars.

After further testing and monitoring, Hurts was diagnosed with a deep vein thrombosis and bilateral pulmonary emboli — lung blood clots, according to the joint statement.

Hurts is clinically stable and has no significant functional limitations. He was placed on anticoagulants, also known as blood thinners, and won't be participating in football while on this medication.

"Jalen's prognosis is very good, and we expect a full recovery. We anticipate that he will have the opportunity to resume contact football activities when off the blood thinners," the statement says.

Hurts will stay active around the team and keep in shape.

"We anticipate that he will have no long-term effects. We are thinking of Jalen and looking forward to a strong recovery," the statement reads.